SCHEMBL26323655

SCHEMBL26323655

COc1cc(CO)cc2oc(C(=O)NN)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.43
MAPT P10636 3/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
RAB9A P51151 4/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
NPC1 O15118 3/20 0.42
NAMPT P43490 1/20 0.42
CA2 P00918 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
POLB P06746 1/20 0.41
HTT P42858 1/20 0.39
CTSD P07339 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6237159 0.84 KDM4E (0.50) GAAMAPTKDM4EALDH1A1RAB9A
SCHEMBL26323917 0.81 ALDH1A1 (0.41) GAAMAPTKDM4EALDH1A1RAB9A
SCHEMBL26323653 0.81 AKR1B1 (0.49) GAAMAPTKDM4EALDH1A1MEN1
SCHEMBL5585274 0.78 HTT (0.54) GAAMAPTKDM4EALDH1A1RAB9A
SCHEMBL5940589 0.71 MAOB (0.48) GAAMAPTKDM4EALDH1A1RAB9A
SCHEMBL15197729 0.70 PABPC1 (0.51) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL17083905 0.70 ALDH1A1 (0.53) MAPTKDM4EALDH1A1RAB9AMEN1
SCHEMBL15197728 0.69 MAOB (0.49) KDM4EALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL5584844 0.69 MAPT (0.49) GAAMAPTKDM4EALDH1A1RAB9A
SCHEMBL15197731 0.67 MAPT (0.52) MAPTALDH1A1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230293487-A1 ANTI-INFLAMMATORY COMPOSITION COMPRISING BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVES KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230293487-A1 ANTI-INFLAMMATORY COMPOSITION COMPRISING BENZOFURAN-BASED N-ACYLHYDRAZONE DERIVATIVES RELA, NFKBIA, IKBKG GAA 1892/4885MAPT 3364/4885KDM4E 2006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.